HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Relationship between Mismatch Negativity and the COMTVal108/158Met Genotype in Schizophrenia.

Abstract
Mismatch negativity (MMN) is a component of auditory event-related potentials that reflects automatic change detection in the brain, showing qualities of endophenotypes in schizophrenia. MMN deficiency is one of the robust findings in patients, and it reflects both cognitive and functional decline. Catechol-o-methyltransferase (COMT) is a key enzyme involved in regulating dopamine transmission within the prefrontal cortex. A preliminary study suggested that the COMTVal108/158Met genotype (rs4680) is related to cognitive function in schizophrenia. Both the COMTVal108/158Met genotype and MMN are related to cognitive function, but no studies have reported on the relationship between MMN and the COMTVal108/158Met genotype in schizophrenia. This study therefore examined the relationship between COMTVal108/158Met genotype and MMN. The duration of MMN was measured, and the COMTVal108/158Met polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism in 49 Japanese schizophrenia patients (Val/Val, n = 21; Met carriers, n = 28). Amplitude and latency of MMN were compared between Val/Val and Met carriers.
AuthorsSho Horikoshi, Tetsuya Shiga, Hiroshi Hoshino, Haruka Ochiai, Keiko Kanno-Nozaki, Kazuko Kanno, Haruka Kaneko, Yasuto Kunii, Itaru Miura, Hirooki Yabe
JournalNeuropsychobiology (Neuropsychobiology) Vol. 77 Issue 4 Pg. 192-196 ( 2019) ISSN: 1423-0224 [Electronic] Switzerland
PMID30326466 (Publication Type: Journal Article)
Copyright© 2018 S. Karger AG, Basel.
Chemical References
  • COMT protein, human
  • Catechol O-Methyltransferase
Topics
  • Adult
  • Auditory Perception (physiology)
  • Brain (physiopathology)
  • Catechol O-Methyltransferase (genetics)
  • Electroencephalography
  • Female
  • Genetic Association Studies
  • Genotype
  • Heterozygote
  • Humans
  • Male
  • Polymorphism, Single Nucleotide
  • Schizophrenia (genetics, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: